BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33016376)

  • 1. Optimal multiwave sampling for regression modeling in two-phase designs.
    Chen T; Lumley T
    Stat Med; 2020 Dec; 39(30):4912-4921. PubMed ID: 33016376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sampling for design-based estimators of regression models.
    Chen T; Lumley T
    Stat Med; 2022 Apr; 41(8):1482-1497. PubMed ID: 34989429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-wave two-phase outcome-dependent sampling designs, with applications to longitudinal binary data.
    Tao R; Mercaldo ND; Haneuse S; Maronge JM; Rathouz PJ; Heagerty PJ; Schildcrout JS
    Stat Med; 2021 Apr; 40(8):1863-1876. PubMed ID: 33442883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical strategies for operationalizing optimal allocation in stratified cluster-based outcome-dependent sampling designs.
    Sauer S; Hedt-Gauthier B; Haneuse S
    Stat Med; 2023 Mar; 42(7):917-935. PubMed ID: 36650619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiwave validation sampling for error-prone electronic health records.
    Shepherd BE; Han K; Chen T; Bian A; Pugh S; Duda SN; Lumley T; Heerman WJ; Shaw PA
    Biometrics; 2023 Sep; 79(3):2649-2663. PubMed ID: 35775996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.
    Steven Ernest C; Nyberg J; Karlsson MO; Hooker AC
    J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):639-54. PubMed ID: 25308776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal sampling allocation for outcome-dependent designs in cluster-correlated data settings.
    Rivera-Rodriguez C; Haneuse S; Sauer S
    Stat Methods Med Res; 2022 Dec; 31(12):2400-2414. PubMed ID: 36039539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranked set sampling in finite populations with bivariate responses: An application to an osteoporosis study.
    Azimian M; Moradi M; Jafari Jozani M; Leslie WD
    Stat Med; 2022 Apr; 41(8):1397-1420. PubMed ID: 35274755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation methods in a sampling survey].
    Warszawski J; Lellouch J
    Rev Epidemiol Sante Publique; 1997 Apr; 45(2):150-68. PubMed ID: 9221444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Phase Sampling Designs for Data Validation in Settings with Covariate Measurement Error and Continuous Outcome.
    Amorim G; Tao R; Lotspeich S; Shaw PA; Lumley T; Shepherd BE
    J R Stat Soc Ser A Stat Soc; 2021 Oct; 184(4):1368-1389. PubMed ID: 34975235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal two-stage sampling for mean estimation in multilevel populations when cluster size is informative.
    Innocenti F; Candel MJ; Tan FE; van Breukelen GJ
    Stat Methods Med Res; 2021 Feb; 30(2):357-375. PubMed ID: 32940135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer.
    Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M
    BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal sampling schedule design for populations of patients.
    Tam VH; Preston SL; Drusano GL
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2888-91. PubMed ID: 12936990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining multiple imputation with raking of weights: An efficient and robust approach in the setting of nearly true models.
    Han K; Shaw PA; Lumley T
    Stat Med; 2021 Dec; 40(30):6777-6791. PubMed ID: 34585424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust risk prediction with biomarkers under two-phase stratified cohort design.
    Payne R; Yang M; Zheng Y; Jensen MK; Cai T
    Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the combination of c- and D-optimal designs: General approaches and applications in dose-response studies.
    Holland-Letz T
    Biometrics; 2017 Mar; 73(1):206-213. PubMed ID: 27218478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the Case-Control Design to Longitudinal Data: Stratified Sampling Based on Repeated Binary Outcomes.
    Schildcrout JS; Schisterman EF; Mercaldo ND; Rathouz PJ; Heagerty PJ
    Epidemiology; 2018 Jan; 29(1):67-75. PubMed ID: 29068838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage sampling designs for external validation of personal risk models.
    Whittemore AS; Halpern J
    Stat Methods Med Res; 2016 Aug; 25(4):1313-29. PubMed ID: 23592716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive response-dependent two-phase designs: Some results on robustness and efficiency.
    Yang C; Diao L; Cook RJ
    Stat Med; 2022 Sep; 41(22):4403-4425. PubMed ID: 35799345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pragmatic approach to the design of population pharmacokinetic studies.
    Roy A; Ette EI
    AAPS J; 2005 Oct; 7(2):E408-20. PubMed ID: 16353920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.